医薬品品質管理ソフトウェア市場規模、シェア、動向分析レポート：用途別、展開モード別、地域別、セグメント予測、2025年～2030年

医薬品品質管理ソフトウェア市場の成長と動向

Grand View Research, Inc.の最新レポートによると、医薬品品質管理ソフトウェアの世界市場規模は、2025～2030年にかけて12.99％のCAGRを記録し、2030年には38億5,000万米ドルに達する見込みです。

医薬品製造に関連する経費の増加、進化し続ける規制状況、製薬部門における技術統合の拡大が、市場成長を後押ししています。品質管理システムは、企業の製品が市場の期待や産業標準を満たすことを保証するものです。品質保証の方法は、欠陥がないことを保証するために採用され、問題に対処するために取られたすべての行動は十分に文書化されます。

堅牢な医薬品品質管理システム（QMS）は、製品の完全性の確保、新製品の市場導入の迅速化、文書管理に関連する時間とコストの削減、問題の特定と解決の支援、サプライヤーのプロセス品質の検証、効果的なトレーニングによる従業員のスキル向上など、いくつかのメリットを企業にもたらします。COVID-19の大流行は市場にプラスの影響を与えました。COVID-19の流行は、世界の医療産業におけるかつてない課題の中で、厳格な品質基準を維持することの重要性を製薬メーカーに認識させました。

この意識の高まりは、医薬品や医療製品の有効性、品質、安全性を保証するための効率的なQMSソリューションに対する需要の急増を促しました。さらに、品質管理システムの導入は、品質管理手順の強化、リスク軽減戦略の実施、規制要件の遵守の確保において企業を支援しました。さらに、今後数年間、市場の主要な競合企業が採用するさまざまな戦略が、市場の拡大を促進するとみられます。

例えば、2021年にArena Solutions, Inc.は、規制情報管理（RIM）ソフトウェアシステムを提供するRimsys Inc.と提携し、品質と製品に焦点を当てた包括的な規制ソリューションを構築しました。この提携により、同社は提供する製品を拡大することができました。さらに、Dassault Systemes傘下のMedidataは2021年4月、リスクベース品質管理（RBQM）スイートに新たに追加されたMedidata Risk Managementを発表しました。Medidata Risk Managementは、臨床業務におけるプロアクティブなモニタリング活動の導入を加速することを目的とした幅広いソリューションで構成されています。

医薬品品質管理ソフトウェア市場レポートハイライト

• 用途別では、データ管理セグメントが2024年の市場を独占し、17.52%の最大売上シェアを占めました。さらに、規制とコンプライアンス管理セグメントは2025～2030年にかけて最も速いCAGRで成長すると予測されます。
• 展開モード別では、クラウド＆ウェブベースセグメントが2024年に77.02％の最大市場シェアを占め、予測期間中に最速のCAGRでの成長が見込まれています。オンプレミスソフトウェアは2024年に大きな収益シェアを占めました。
• 北米の医薬品品質管理ソフトウェア市場は、2024年に38.63%の最大の収益シェアを占めました。米国の医薬品品質管理ソフトウェア市場は、製薬・バイオ医薬品産業における法規制遵守の重視と業務効率向上のニーズの高まりにより、大きな成長を遂げています。
• アジア太平洋の医薬品品質管理ソフトウェア市場は、米国食品医薬品局（FDA）や欧州医薬品庁（EMA）などの保健当局や現地の規制当局が課す規制要件の増加により、2025～2030年にかけて最も速いCAGRで成長する展望です。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 医薬品品質管理ソフトウェア市場の変数、動向、範囲

• 市場系統の展望
  • 親市場の展望
  • 関連/補助的な市場展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 医薬品品質管理ソフトウェア市場分析ツール
  • 産業分析-ポーターのファイブフォース分析
  • PESTEL分析
• 技術の進歩
• 使用事例

第4章 医薬品品質管理ソフトウェア市場：用途別、推定・動向分析

• セグメントダッシュボード
• 世界の医薬品品質管理ソフトウェア市場の用途変動分析
• 世界の医薬品品質管理ソフトウェア市場規模と動向分析、用途別、2018～2030年
• データ管理
• トレーニング管理
• サプライヤー管理
• 規制とコンプライアンス管理
• 是正措置予防措置（CAPA）管理
• 監査管理
• 変更管理
• 不適合管理
• 検査管理
• リスク管理
• その他

第5章 医薬品品質管理ソフトウェア市場：展開モード別、推定・動向分析

• セグメントダッシュボード
• 世界の医薬品品質管理ソフトウェア市場の展開モード変動分析
• 世界の医薬品品質管理ソフトウェア市場規模と動向分析、展開モード別、2018～2030年
• クラウドとウェブベース
• オンプレミス

第6章 医薬品品質管理ソフトウェア市場：地域別、推定・動向分析

• 地域別市場シェア分析、2024年と2030年
• 地域別市場ダッシュボード
• 市場規模と予測動向分析、2018～2030年
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第7章 競合情勢

• 企業/競合の分類
• 戦略マッピング
• 企業市況分析、2024年
• 企業プロファイル/上場企業
  • MasterControl Solutions, Inc.
  • AmpleLogic
  • Qualio
  • Pilgrim（IQVIA）
  • QT9
  • Sparta Systems（TrackWise）
  • AssurX, Inc
  • Dassault Systemes
  • ETQ, LLC（Hexagon）
  • Veeva Systems
  • Qualityze Inc.
  • Ideagen

List of Tables

• Table 1 List of abbreviations
• Table 2 Global pharmaceutical quality management software market, by region, 2018 - 2030 (USD Million)
• Table 3 Global pharmaceutical quality management software market, by application, 2018 - 2030 (USD Million)
• Table 4 Global pharmaceutical quality management software market, by deployment mode, 2018 - 2030 (USD Million)
• Table 5 North America pharmaceutical quality management software market, by country, 2018 - 2030 (USD Million)
• Table 6 North America pharmaceutical quality management software market, by application, 2018 - 2030 (USD Million)
• Table 7 North America pharmaceutical quality management software market, by deployment mode, 2018 - 2030 (USD Million)
• Table 8 U.S. pharmaceutical quality management software market, by application, 2018 - 2030 (USD Million)
• Table 9 U.S. pharmaceutical quality management software market, by deployment mode, 2018 - 2030 (USD Million)
• Table 10 Canada pharmaceutical quality management software market, by application, 2018 - 2030 (USD Million)
• Table 11 Canada pharmaceutical quality management software market, by deployment mode, 2018 - 2030 (USD Million)
• Table 12 Mexico pharmaceutical quality management software market, by application, 2018 - 2030 (USD Million)
• Table 13 Mexico pharmaceutical quality management software market, by deployment mode, 2018 - 2030 (USD Million)
• Table 14 Europe pharmaceutical quality management software market, by country, 2018 - 2030 (USD Million)
• Table 15 Europe pharmaceutical quality management software market, by application, 2018 - 2030 (USD Million)
• Table 16 Europe pharmaceutical quality management software market, by deployment mode, 2018 - 2030 (USD Million)
• Table 17 UK pharmaceutical quality management software market, by application, 2018 - 2030 (USD Million)
• Table 18 UK pharmaceutical quality management software market, by deployment mode, 2018 - 2030 (USD Million)
• Table 19 Germany pharmaceutical quality management software market, by application, 2018 - 2030 (USD Million)
• Table 20 Germany pharmaceutical quality management software market, by deployment mode, 2018 - 2030 (USD Million)
• Table 21 France pharmaceutical quality management software market, by application, 2018 - 2030 (USD Million)
• Table 22 France pharmaceutical quality management software market, by deployment mode, 2018 - 2030 (USD Million)
• Table 23 Italy pharmaceutical quality management software market, by application, 2018 - 2030 (USD Million)
• Table 24 Italy pharmaceutical quality management software market, by deployment mode, 2018 - 2030 (USD Million)
• Table 25 Spain pharmaceutical quality management software market, by application, 2018 - 2030 (USD Million)
• Table 26 Spain pharmaceutical quality management software market, by deployment mode, 2018 - 2030 (USD Million)
• Table 27 Denmark pharmaceutical quality management software market, by application, 2018 - 2030 (USD Million)
• Table 28 Denmark pharmaceutical quality management software market, by deployment mode, 2018 - 2030 (USD Million)
• Table 29 Sweden pharmaceutical quality management software market, by application, 2018 - 2030 (USD Million)
• Table 30 Sweden pharmaceutical quality management software market, by deployment mode, 2018 - 2030 (USD Million)
• Table 31 Norway pharmaceutical quality management software market, by application, 2018 - 2030 (USD Million)
• Table 32 Norway pharmaceutical quality management software market, by deployment mode, 2018 - 2030 (USD Million)
• Table 33 Asia Pacific pharmaceutical quality management software market, by country, 2018 - 2030 (USD Million)
• Table 34 Asia Pacific pharmaceutical quality management software market, by application, 2018 - 2030 (USD Million)
• Table 35 Asia Pacific pharmaceutical quality management software market, by deployment mode, 2018 - 2030 (USD Million)
• Table 36 China pharmaceutical quality management software market, by application, 2018 - 2030 (USD Million)
• Table 37 China pharmaceutical quality management software market, by deployment mode, 2018 - 2030 (USD Million)
• Table 38 Japan pharmaceutical quality management software market, by application, 2018 - 2030 (USD Million)
• Table 39 Japan pharmaceutical quality management software market, by deployment mode, 2018 - 2030 (USD Million)
• Table 40 India pharmaceutical quality management software market, by application, 2018 - 2030 (USD Million)
• Table 41 India pharmaceutical quality management software market, by deployment mode, 2018 - 2030 (USD Million)
• Table 42 South Korea pharmaceutical quality management software market, by application, 2018 - 2030 (USD Million)
• Table 43 South Korea pharmaceutical quality management software market, by deployment mode, 2018 - 2030 (USD Million)
• Table 44 Australia pharmaceutical quality management software market, by application, 2018 - 2030 (USD Million)
• Table 45 Australia pharmaceutical quality management software market, by deployment mode, 2018 - 2030 (USD Million)
• Table 46 Thailand pharmaceutical quality management software market, by application, 2018 - 2030 (USD Million)
• Table 47 Thailand pharmaceutical quality management software market, by deployment mode, 2018 - 2030 (USD Million)
• Table 48 Latin America pharmaceutical quality management software market, by country, 2018 - 2030 (USD Million)
• Table 49 Latin America pharmaceutical quality management software market, by application, 2018 - 2030 (USD Million)
• Table 50 Latin America pharmaceutical quality management software market, by deployment mode, 2018 - 2030 (USD Million)
• Table 51 Brazil pharmaceutical quality management software market, by application, 2018 - 2030 (USD Million)
• Table 52 Brazil pharmaceutical quality management software market, by deployment mode, 2018 - 2030 (USD Million)
• Table 53 Argentina pharmaceutical quality management software market, by application, 2018 - 2030 (USD Million)
• Table 54 Argentina pharmaceutical quality management software market, by deployment mode, 2018 - 2030 (USD Million)
• Table 55 MEA pharmaceutical quality management software market, by country, 2018 - 2030 (USD Million)
• Table 56 MEA pharmaceutical quality management software market, by application, 2018 - 2030 (USD Million)
• Table 57 MEA pharmaceutical quality management software market, by deployment mode, 2018 - 2030 (USD Million)
• Table 58 South Africa pharmaceutical quality management software market, by application, 2018 - 2030 (USD Million)
• Table 59 South Africa pharmaceutical quality management software market, by deployment mode, 2018 - 2030 (USD Million)
• Table 60 Saudi Arabia pharmaceutical quality management software market, by application, 2018 - 2030 (USD Million)
• Table 61 Saudi Arabia pharmaceutical quality management software market, by deployment mode, 2018 - 2030 (USD Million)
• Table 62 UAE pharmaceutical quality management software market, by application, 2018 - 2030 (USD Million)
• Table 63 UAE pharmaceutical quality management software market, by deployment mode, 2018 - 2030 (USD Million)
• Table 64 Kuwait pharmaceutical quality management software market, by application, 2018 - 2030 (USD Million)
• Table 65 Kuwait pharmaceutical quality management software market, by deployment mode, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Market formulation & validation
• Fig. 4 Pharmaceutical Quality Management Software market: Market outlook
• Fig. 5 Pharmaceutical Quality Management Software market: Segment outlook
• Fig. 6 Pharmaceutical Quality Management Software market: Competitive landscape outlook
• Fig. 7 Parent market outlook
• Fig. 8 Pharmaceutical quality management software market driver impact
• Fig. 9 Pharmaceutical quality management software market restraint impact
• Fig. 10 Pharmaceutical quality management software market: Application outlook and key takeaways
• Fig. 11 Pharmaceutical quality management software market: Application movement analysis
• Fig. 12 Data management market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 13 Training management market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 14 Supplier management market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 15 Regulatory and supplier management market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 16 Corrective action and preventive action (CAPA) management market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 17 Audit management market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 18 Change management market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 19 Non-conformances management market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 20 Inspection management market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 21 Risk management market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 22 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 23 Pharmaceutical quality management software market: Deployment mode outlook and key takeaways
• Fig. 24 Pharmaceutical quality management software market: Deployment mode movement analysis
• Fig. 25 Cloud & Web-based market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 26 On-premise market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 27 Global pharmaceutical quality management software market: Regional outlook and key takeaways
• Fig. 28 Global pharmaceutical quality management software market: Regional movement analysis
• Fig. 29 North America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 30 Key country dynamics
• Fig. 31 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 32 Key country dynamics
• Fig. 33 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 34 Key country dynamics
• Fig. 35 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 36 Key country dynamics
• Fig. 37 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 38 UK market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 39 Key country dynamics
• Fig. 40 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 41 Key country dynamics
• Fig. 42 France market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 43 Key country dynamics
• Fig. 44 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 45 Key country dynamics
• Fig. 46 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 47 Key country dynamics
• Fig. 48 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49 Key country dynamics
• Fig. 50 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Key country dynamics
• Fig. 52 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 53 Key country dynamics
• Fig. 54 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 55 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 56 Key country dynamics
• Fig. 57 China market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 58 Key country dynamics
• Fig. 59 India market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 60 Key country dynamics
• Fig. 61 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 62 Key country dynamics
• Fig. 63 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 64 Key country dynamics
• Fig. 65 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 66 Key country dynamics
• Fig. 67 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 68 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 69 Key country dynamics
• Fig. 70 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 71 Key country dynamics
• Fig. 72 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 73 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 74 Key country dynamics
• Fig. 75 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 76 Key country dynamics
• Fig. 77 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 78 Key country dynamics
• Fig. 79 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 80 Key country dynamics

Pharmaceutical Quality Management Software Market Growth & Trends:

The global pharmaceutical quality management software market size is expected to reach USD 3.85 billion by 2030, registering a CAGR of 12.99% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market growth is being propelled by the increasing expenses associated with drug manufacturing, the ever-evolving regulatory landscape, and the expanding integration of technology within the pharmaceutical sector. A quality management system ensures that a company's products meet market expectations and industry standards. Quality assurance methods are employed to ensure there are no defects, and all actions taken to address issues are well-documented.

A robust pharmaceutical quality management system (QMS) offers several advantages to businesses, including ensuring product integrity, expediting the introduction of new products to the market, reducing the time and cost associated with document management, aiding in the identification and resolution of issues, verifying the quality of supplier processes, and enabling employee skill enhancement through effective training. The COVID-19 pandemic positively affected the market. It led pharmaceutical manufacturers to recognize the significance of maintaining stringent quality standards amidst unprecedented challenges in the global healthcare industry.

This heightened awareness drove a surge in demand for efficient QMS solutions to guarantee the effectiveness, quality, and safety of pharmaceuticals and medical products. In addition, the adoption of quality management systems aided businesses in enhancing their quality management procedures, implementing risk mitigation strategies, and ensuring adherence to regulatory requirements. Furthermore, the various strategies employed by the key market competitors over the next few years are likely to drive market expansion.

For instance, in 2021, Arena Solutions, Inc., partnered with Rimsys Inc., a company that offers regulatory information management (RIM) software systems, to create a comprehensive quality and product-focused regulatory solution. This collaboration allowed the organization to expand its product offerings. In addition, in April 2021, Medidata, a company under Dassault Systemes, introduced Medidata Risk Management, a new addition to its Risk-Based Quality Management (RBQM) suite, which comprises a wide range of solutions aimed at speeding up the adoption of proactive oversight activities in clinical operations

Pharmaceutical Quality Management Software Market Report Highlights:

• Based on applications, the data management segment dominated the market in 2024 and accounted for the largest revenue share of 17.52%. Furthermore, the regulatory and compliance management segment is expected to grow at the fastest CAGR from 2025 to 2030.
• Based on deployment mode, the cloud & web-based segment held the largest market share of 77.02% in 2024 and is expected to register growth at the fastest CAGR during the forecast period. On-premises software accounted for a significant revenue share in 2024.
• North America pharmaceutical quality management software market dominated with the largest revenue share of 38.63% in 2024. Pharmaceutical quality management software market in the U.S. is experiencing significant growth, driven by an increasing emphasis on regulatory compliance and the need for enhanced operational efficiency within the pharmaceutical and biopharmaceutical industry.
• Pharmaceutical quality management software market in Asia Pacific is poised to grow at the fastest CAGR from 2025 to 2030 due to the increasing regulatory requirements imposed by health authorities, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), and local regulatory agencies.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Application Segment
  • 1.2.2. Deployment Mode
• 1.3. Information analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data validation & publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
  • 1.8.1. Commodity Flow Analysis
• 1.9. Total Market: CAGR Calculation
• 1.10. Objectives
  • 1.10.1. Objective 1
  • 1.10.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights Landscape

Chapter 3. Pharmaceutical Quality Management Software Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing cost of drugs manufacturing
    • 3.2.1.2. Increasing technological adoption in pharmaceutical companies
    • 3.2.1.3. Growing demand to comply with regulatory requirements
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Data security and privacy concerns
    • 3.2.2.2. A shortage of skilled professionals
• 3.3. Pharmaceutical Quality Management Software Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
    • 3.3.2.4. Environmental Landscape
    • 3.3.2.5. Legal Landscape
    • 3.3.2.6. Social Landscape
• 3.4. Technological Advancement
• 3.5. Case Studies

Chapter 4. Pharmaceutical Quality Management Software Market: Application Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Pharmaceutical Quality Management Software Market Application Movement Analysis
• 4.3. Global Pharmaceutical Quality Management Software Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 4.4. Data Management
  • 4.4.1. Data Management Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Training Management
  • 4.5.1. Training Management Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Supplier Management
  • 4.6.1. Supplier Management Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.7. Regulatory and Compliance Management
  • 4.7.1. Regulatory and Compliance Management Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.8. Corrective Action Preventive Action (CAPA) Management
  • 4.8.1. Corrective Action Preventive Action (CAPA) Management Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.9. Audit Management
  • 4.9.1. Audit Management Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.10. Change Management
  • 4.10.1. Change Management Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.11. Non-conformances Management
  • 4.11.1. Non-conformances Management Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.12. Inspection Management
  • 4.12.1. Inspection Management Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.13. Risk Management
  • 4.13.1. Risk Management Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.14. Others
  • 4.14.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Pharmaceutical Quality Management Software Market: Deployment Mode Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Pharmaceutical Quality Management Software Market Deployment Mode Movement Analysis
• 5.3. Global Pharmaceutical Quality Management Software Market Size & Trend Analysis, by Deployment Mode, 2018 to 2030 (USD Million)
• 5.4. Cloud & Web Based
  • 5.4.1. Cloud & Web Based Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. On-premise
  • 5.5.1. On-premise Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Pharmaceutical Quality Management Software Market: Regional Estimates & Trend Analysis

• 6.1. Regional Market Share Analysis, 2024 & 2030
• 6.2. Regional Market Dashboard
• 6.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
• 6.4. North America
  • 6.4.1. U.S.
    • 6.4.1.1. Key country dynamics
    • 6.4.1.2. Regulatory framework
    • 6.4.1.3. Competitive scenario
    • 6.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.2. Canada
    • 6.4.2.1. Key country dynamics
    • 6.4.2.2. Regulatory framework
    • 6.4.2.3. Competitive scenario
    • 6.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.3. Mexico
    • 6.4.3.1. Key country dynamics
    • 6.4.3.2. Regulatory framework
    • 6.4.3.3. Competitive scenario
    • 6.4.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Europe
  • 6.5.1. UK
    • 6.5.1.1. Key country dynamics
    • 6.5.1.2. Regulatory framework
    • 6.5.1.3. Competitive scenario
    • 6.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.2. Germany
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Regulatory framework
    • 6.5.2.3. Competitive scenario
    • 6.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.3. France
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Regulatory framework
    • 6.5.3.3. Competitive scenario
    • 6.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.4. Italy
    • 6.5.4.1. Key country dynamics
    • 6.5.4.2. Regulatory framework
    • 6.5.4.3. Competitive scenario
    • 6.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.5. Spain
    • 6.5.5.1. Key country dynamics
    • 6.5.5.2. Regulatory framework
    • 6.5.5.3. Competitive scenario
    • 6.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.6. Norway
    • 6.5.6.1. Key country dynamics
    • 6.5.6.2. Regulatory framework
    • 6.5.6.3. Competitive scenario
    • 6.5.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.7. Sweden
    • 6.5.7.1. Key country dynamics
    • 6.5.7.2. Regulatory framework
    • 6.5.7.3. Competitive scenario
    • 6.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.8. Denmark
    • 6.5.8.1. Key country dynamics
    • 6.5.8.2. Regulatory framework
    • 6.5.8.3. Competitive scenario
    • 6.5.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Asia Pacific
  • 6.6.1. Japan
    • 6.6.1.1. Key country dynamics
    • 6.6.1.2. Regulatory framework
    • 6.6.1.3. Competitive scenario
    • 6.6.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.2. China
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Regulatory framework
    • 6.6.2.3. Competitive scenario
    • 6.6.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.3. India
    • 6.6.3.1. Key country dynamics
    • 6.6.3.2. Regulatory framework
    • 6.6.3.3. Competitive scenario
    • 6.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.4. Australia
    • 6.6.4.1. Key country dynamics
    • 6.6.4.2. Regulatory framework
    • 6.6.4.3. Competitive scenario
    • 6.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.5. South Korea
    • 6.6.5.1. Key country dynamics
    • 6.6.5.2. Regulatory framework
    • 6.6.5.3. Competitive scenario
    • 6.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.6. Thailand
    • 6.6.6.1. Key country dynamics
    • 6.6.6.2. Regulatory framework
    • 6.6.6.3. Competitive scenario
    • 6.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. Latin America
  • 6.7.1. Brazil
    • 6.7.1.1. Key country dynamics
    • 6.7.1.2. Regulatory framework
    • 6.7.1.3. Competitive scenario
    • 6.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.2. Argentina
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Regulatory framework
    • 6.7.2.3. Competitive scenario
    • 6.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 6.8. MEA
  • 6.8.1. South Africa
    • 6.8.1.1. Key country dynamics
    • 6.8.1.2. Regulatory framework
    • 6.8.1.3. Competitive scenario
    • 6.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8.2. Saudi Arabia
    • 6.8.2.1. Key country dynamics
    • 6.8.2.2. Regulatory framework
    • 6.8.2.3. Competitive scenario
    • 6.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8.3. UAE
    • 6.8.3.1. Key country dynamics
    • 6.8.3.2. Regulatory framework
    • 6.8.3.3. Competitive scenario
    • 6.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8.4. Kuwait
    • 6.8.4.1. Key country dynamics
    • 6.8.4.2. Regulatory framework
    • 6.8.4.3. Competitive scenario
    • 6.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Company/Competition Categorization
• 7.2. Strategy Mapping
• 7.3. Company Market Position Analysis, 2024
• 7.4. Company Profiles/Listing
  • 7.4.1. MasterControl Solutions, Inc.
    • 7.4.1.1. Company overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Product benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. AmpleLogic
    • 7.4.2.1. Company overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Product benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. Qualio
    • 7.4.3.1. Company overview
    • 7.4.3.2. Financial performance
    • 7.4.3.3. Product benchmarking
    • 7.4.3.4. Strategic initiatives
  • 7.4.4. Pilgrim (IQVIA)
    • 7.4.4.1. Company overview
    • 7.4.4.2. Financial performance
    • 7.4.4.3. Product benchmarking
    • 7.4.4.4. Strategic initiatives
  • 7.4.5. QT9
    • 7.4.5.1. Company overview
    • 7.4.5.2. Financial performance
    • 7.4.5.3. Product benchmarking
    • 7.4.5.4. Strategic initiatives
  • 7.4.6. Sparta Systems (TrackWise)
    • 7.4.6.1. Company overview
    • 7.4.6.2. Financial performance
    • 7.4.6.3. Product benchmarking
    • 7.4.6.4. Strategic initiatives
  • 7.4.7. AssurX, Inc
    • 7.4.7.1. Company overview
    • 7.4.7.2. Financial performance
    • 7.4.7.3. Product benchmarking
    • 7.4.7.4. Strategic initiatives
  • 7.4.8. Dassault Systemes
    • 7.4.8.1. Company overview
    • 7.4.8.2. Financial performance
    • 7.4.8.3. Product benchmarking
    • 7.4.8.4. Strategic initiatives
  • 7.4.9. ETQ, LLC (Hexagon)
    • 7.4.9.1. Company overview
    • 7.4.9.2. Financial performance
    • 7.4.9.3. Product benchmarking
    • 7.4.9.4. Strategic initiatives
  • 7.4.10. Veeva Systems
    • 7.4.10.1. Company overview
    • 7.4.10.2. Financial performance
    • 7.4.10.3. Product benchmarking
    • 7.4.10.4. Strategic initiatives
  • 7.4.11. Qualityze Inc.
    • 7.4.11.1. Company overview
    • 7.4.11.2. Financial performance
    • 7.4.11.3. Product benchmarking
    • 7.4.11.4. Strategic initiatives
  • 7.4.12. Ideagen
    • 7.4.12.1. Company overview
    • 7.4.12.2. Financial performance
    • 7.4.12.3. Product benchmarking
    • 7.4.12.4. Strategic initiatives